Kazia Therapeutics Limited
KZIA
$3.30
-$0.2395-6.77%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -157.48% | -151.13% | 35.64% | 37.81% | 45.57% |
| Total Depreciation and Amortization | -1.35% | -3.79% | -0.91% | -4.26% | -6.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 298.23% | 293.35% | -48.50% | -50.24% | -57.20% |
| Change in Net Operating Assets | 380.42% | 368.56% | -66.48% | -67.61% | 102.97% |
| Cash from Operations | 49.57% | 50.81% | 28.72% | 31.12% | 47.81% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -82.88% | -82.88% | -20.21% | -20.21% | 79.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 86.08% | 86.08% | -- | -- | 18.67% |
| Cash from Financing | -82.93% | -83.35% | -19.51% | -22.22% | 79.42% |
| Foreign Exchange rate Adjustments | 34.72% | 31.37% | -528.00% | -507.69% | -87.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -320.98% | -315.51% | 44.00% | 45.89% | 110.16% |